Calcification of biomaterials used in prosthetic heart valves has been a challenging issue in cardiovascular surgery. The objective of this work is to compare the efficiency of polyvinyl alcohol (PVA) and tannic acid (TA) modification of xenomaterials, pre-stabilized with glutaraldehyde (GA) and ethylene glycol diglycidyl ether (EGDE), in reducing calcification. Analysis of mechanical properties evaluated under uniaxial tension, showed a significant increase in the tensile strength of the test samples compared to the control (unmodified) samples (p < 0.05). Additional treatment of GA-fixed tissue with PVA and TA significantly reduced the amount of calcium in the samples implanted into rats for a 60-day follow-up (p < 0.05). The level ...
The purpose of this study was to determine if phosphocitrate (PC), a naturally occurring inhibitor o...
The lifespan of biological heart valve prostheses available in the market is limited due to structur...
Glutaraldehyde fixation of bioprosthetic tissue has been used successfully for almost 40 years. Howe...
In this study an attempt was made to find an optimum method of chemical treatment to prevent the cal...
Calcification is the principal cause of the clinical failure of bioprosthetic heart valves fabricate...
Every year a lot of people suffering from congenital or acquired heart valve diseases overcome heart...
Calcification is a recurrent problem in patients suffering from heart valve disease and it is the ma...
Calcification plays a major role in the failure of biopros-thetic and other tissue heart valve subst...
A novel chemical modification of biological tissues was developed aimed at improving biocompatibilit...
Objectives: the purpose of this study was to evaluate the impact of a polyphenols-based treatment on...
To study the process of calcification in bioprostheses, valve leaflets were implanted subcutaneously...
Calcification is the most frequent cause of clinical dysfunction of glutaraldehyde treated bioprosth...
Cardiovascular implant mineralization involving bioprosthetic materials, such as glutaraldehyde cros...
BACKGROUND AND AIM OF THE STUDY: Glutaraldehyde is considered a promoter of calcification by the act...
Calcification of bioprosthetic heart valves fabricated from glutaraldehyde pretreated bovine pericar...
The purpose of this study was to determine if phosphocitrate (PC), a naturally occurring inhibitor o...
The lifespan of biological heart valve prostheses available in the market is limited due to structur...
Glutaraldehyde fixation of bioprosthetic tissue has been used successfully for almost 40 years. Howe...
In this study an attempt was made to find an optimum method of chemical treatment to prevent the cal...
Calcification is the principal cause of the clinical failure of bioprosthetic heart valves fabricate...
Every year a lot of people suffering from congenital or acquired heart valve diseases overcome heart...
Calcification is a recurrent problem in patients suffering from heart valve disease and it is the ma...
Calcification plays a major role in the failure of biopros-thetic and other tissue heart valve subst...
A novel chemical modification of biological tissues was developed aimed at improving biocompatibilit...
Objectives: the purpose of this study was to evaluate the impact of a polyphenols-based treatment on...
To study the process of calcification in bioprostheses, valve leaflets were implanted subcutaneously...
Calcification is the most frequent cause of clinical dysfunction of glutaraldehyde treated bioprosth...
Cardiovascular implant mineralization involving bioprosthetic materials, such as glutaraldehyde cros...
BACKGROUND AND AIM OF THE STUDY: Glutaraldehyde is considered a promoter of calcification by the act...
Calcification of bioprosthetic heart valves fabricated from glutaraldehyde pretreated bovine pericar...
The purpose of this study was to determine if phosphocitrate (PC), a naturally occurring inhibitor o...
The lifespan of biological heart valve prostheses available in the market is limited due to structur...
Glutaraldehyde fixation of bioprosthetic tissue has been used successfully for almost 40 years. Howe...